1. Doherty, J.E., Flanigan, W.J., Murphy, M.L., Bullock, R.T., Dalrymple, G.L., Beard, O.W., Perkins, W.H.: Tritiated digoxin. XIV. Enterohepatic circulation, absorption and excretion studies in human volunteers. Circulation42, 867?873 (1970)
2. Gold, H., Modell, W., Kwit, N.T., Shane, S.J., Dayrit, C., Kramer, M.L., Zahm, W., Otto, H.L.: Comparison of ouabain, with strophanthidin-3-acetate by intravenous injection in man. J. Pharmacol. exp. Ther.94, 39?47 (1948)
3. Haustein, K.-O.: Zur Herzwirkung des 16-epi-Gitoxins. In: Verhandl. Dtsch. Ges. Exptl. Med., (ed. K. Lohmann), S. 164?168. Berlin: Verlag Volk und Gesundheit 1967
4. Haustein, K.-O.: Extraordinary cardiac effects of 16-epi-gitoxin in comparison to ouabain in cats and dogs. Pharmacology15, 178?190 (1977)
5. Haustein, K.-O., Markwardt, F., Repke, K.: Different relationship between therapeutic and toxic action of 16-epi-gitoxin, gitoxin, and ouabain on isolated cardiac preparations. Europ. J. Pharmacol.10, 1?10 (1970)